Close Menu

BMS

Researchers explored the predictive value of using mismatch repair deficiency and PD-L1 expression to assess which cancer patients are likely to respond to anti-PD-1 treatments.

A blueprint that four drugmakers released during the meeting represents an initial effort to explore the analytical differences between CDx for drugs in the same class.

The companies are collaborating on a companion diagnostic intended to identify best responders to the PD-1 inhibitor.

NEW YORK (GenomeWeb) — Danaher's Leica Biosystems said today that it has made a deal with Bristol-Myers Squibb to collaborate in developing companion diagnostics to predict which patients will respond to BMS-developed targeted therapies.

Can drugmakers be held liable for failing to aggressively warn consumers that patients with certain genetic markers will not respond or will have limited response to their drugs beyond just mentioning this information in drug labeling?

NEW YORK (GenomeWeb News) – IncellDx and Bristol-Myers Squibb have signed an agreement to develop a molecular test that may eventually be used as a companion diagnostic to identify best responders to an investigational drug in BMS's pipeline.

After appointing a new CEO this summer, SQI Diagnostics is continuing its focus on services to pharmaceutical partners in providing custom multiplex immunogenicity panels, with its pipeline of in vitro diagnostics assays as a second priority, the company said this week.

The Multiple Myeloma Research Foundation is hoping that an open-access research portal containing detailed longitudinal clinical and genomic data from multiple myeloma patients will spur collaborative research that advances much needed molecularly-targeted treatments.

Pages

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.